>

WEBINARS

RSS
>

MEETINGS / EVENTS

RSS
>

FDA MEDWATCH ALERTS

RSS

May 20, 2013

All Sterile Drug Products Made and Distributed By NuVision Pharmacy Dallas Facility: Recall - Lack Of Sterility Assurance

Summary:

All Sterile Drug Products Made and Distributed By NuVision Pharmacy Dallas Facility

May 14, 2013

Zolpidem Containing Products: Drug Safety Communication - FDA Requires Lower Recommended Doses

Summary:

Zolpidem Containing Products Drug Safety Communication

May 09, 2013

The Compounding Shop: FDA News Release - Lack of Sterility Assurance of Drug Products

Summary:

The Compounding Shop FDA News Release Lack of Sterility

>

ASA FEATURED PRODUCT

Add this product to your shopping cart

Anesthesiology Continuing Education (ACE) Program

SKU: 30702-13CE

... Read more »

Single Copies, Member Price: $360

ASA Initial Reaction to Final ACO Rule

Monday, October 31, 2011

Based on ASA's quick, preliminary analysis of the Accountable Care Organization (ACO) final regulations, it does not seem that anesthesiologists and specialists, in general, will have much of a role in ACOs.  While CMS made significant changes in the final rule, the program is still directed toward primary care. We will be posting a more comprehensive analysis of the changes in the final rule based on ASA’s comment letter to CMS on the proposed regulations.

To learn more about ACOs, visit ASA's ACO page.

« Back to Washington Alerts